Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy

Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy

Ning Xu,1,2 Benjamin Tse,1,2 Lu Yang,1,2 Tiffany CY Tang,1,2 Michelle Haber,1,2 Kenneth Micklethwaite,3– 6 Alla Dolnikov1,2 1Children’s Cancer Institute, University of New South Wales, Sydney, NSW, Australia; 2School of Women’s and Children’s Health, Universit...

Full description

Bibliographic Details
Main Authors: Xu N, Tse B, Yang L, Tang TCY, Haber M, Micklethwaite K, Dolnikov A
Format: Article
Language:English
Published: Dove Medical Press 2021-04-01
Series:ImmunoTargets and Therapy
Subjects:
car t cells
leukemia
aza
patient-derived xenografts
gene expression
Online Access:https://www.dovepress.com/priming-leukemia-with-5-azacytidine-enhances-car-t-cell-therapy-peer-reviewed-fulltext-article-ITT

Internet

https://www.dovepress.com/priming-leukemia-with-5-azacytidine-enhances-car-t-cell-therapy-peer-reviewed-fulltext-article-ITT

Similar Items